心力衰竭合并心律失常患者行胺碘酮治疗疗效的研究.docVIP

心力衰竭合并心律失常患者行胺碘酮治疗疗效的研究 　　【摘要】 目的：研究胺碘酮对心力衰竭合并心律失常患者的临床疗效。方法：选取2011年5月-2013年5月笔者所在医院收治的80例心力衰竭合并心律失常患者，按照治疗方法的不同将其分为两组，对照组和观察组，各40例。对照组进行常规治疗，观察组在常规治疗的基础上静脉注射胺碘酮溶液，观察并记录两组患者的疗效以及不良反应。结果：观察组治疗总有效率为95.0%，高于对照组的65.0%，差异有统计学意义（P0.05）。观察组心电图改善情况优于对照组（P0.05），不良反应发生情况少于对照组（P0.05）。结论：胺碘酮治疗心力衰竭合并心律失常能够改善患者的心功能，有提升治疗效果作用，未出现严重的不良反应，疗效明显且安全性高，值得在临床上推广使用。 　　【关键词】 心力衰竭； 心律失常； 胺碘酮 　　中图分类号 R541.7 文献标识码 A 文章编号 1674-6805（2014）11-0003-02 　　Research on Treatment Efficacy of Patients with Heart Failure Combining Arrhythmia Subjecting to Amiodarone/YANG Chong-zhe，ZHANG Ying.//Chinese and Foreign Medical Research，2014，12（11）：3-4 　　【Abstract】 Objective：To study clinical efficacy of amiodarone on patients with heart failure combining arrhythmia.Method：Selection from May 2011 to May 2013， the author’s hospital treated 80 cases of patients with heart failure combined arrhythmia， according to the different method of treatment to be divided into two groups， control group and observation group， 40 cases in each. Control group routine treatment， the observation group on the basis of routine therapy intravenous amiodarone solution， observe and record the curative effect and adverse reaction of two groups of patients.Result：Observation group treatment the total effective rate was 95.0% higher than that of control group 65.0%， the difference was statistically significant （P0.05）. Group of electrocardiogram （ecg） was observed is better than that of control group（P0.05）， adverse reaction happening less than the control group（P0.05）.Conclusion：The treatment of amiodarone on heart failure combining arrhythmia is capable of improving cardiac function of patients and delivers the effect of improving therapeutic effect， no serious adverse reaction is found， the efficacy is of significance and high safety， being worthy of promotion and application in clinical practices. 　　【Key words】 Heart Failure； Arrhythmias； Amiodarone 　　First-author’s address：The First People’s Hospital in Guangzhou，Guangzhou 5